Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT
Biostar Pharmaceuticals Revenue
Biostar Pharmaceuticals had revenue of $317.79K in the twelve months ending September 30, 2017, down -91.86% year-over-year. In the year 2016, Biostar Pharmaceuticals had annual revenue of $2.38M, down -91.21%.
Revenue (ttm)
317.79K
Revenue Growth
-91.86%
P/S Ratio
0.00
Revenue / Employee
1.59K
Employees
200
Market Cap
3.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 2.38M | -24.75M | -91.21% |
| Dec 31, 2015 | 27.13M | -34.29M | -55.83% |
| Dec 31, 2014 | 61.42M | 8.69M | 16.48% |
| Dec 31, 2013 | 52.73M | 3.41M | 6.92% |
| Dec 31, 2012 | 49.32M | -42.65M | -46.37% |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |